This study aimed to map out and measure the experiences of women
living with ovarian cancer over time and identify areas of improvement
as well as good practice. It also highlights areas of concern such as
the delays found in diagnosis; the negative impact of the current
financial climate on clinical nurse specialists' ability to support
patients; and the fall in the number of women being offered clinical
trials.